Dietary supplementation restored performance on spatial memory (Morris water maze) and temporal memory tasks, reduced oxidative damage to RNA in the hippocampus, and reversed age-associated mitochondrial structural decay
This signal can help reduce overall food intake
The magnitude of cardiovascular risk reduction echoed the pivotal cardiovascular outcome trials studying SGLT2is versus placebo, in which the baseline use of GLP-1 RAs was minimal
Key lipid changes with GLP-1 receptor agonists include: Triglycerides: 15-25% reduction Total cholesterol: 3-8% reduction LDL cholesterol: 3-7% reduction HDL cholesterol: 2-5% increase Non-HDL cholesterol: 5-10% reduction The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease who were receiving standard background care
This is in sharp contrast to GSH, which can enter cells only slowly via specific transporters
The most clinically serious rare side effects are acute pancreatitis, gallbladder disease, and severe allergic reactions